Normal people can block the effects of taking Bituvi/Bikonprenol tablets for 28 days

Biktarvy is a combination antiretroviral drug consisting of bictegravir, emtricitabine and tenofovir alafenamide, TAF), mainly used to treat HIV-1 infection [AIDS (AIDS)]. In recent years, the application of Bikeren Prenol Tablets in non-occupational post-exposure prophylaxis (PEP) has also received more and more attention. For healthy HIV-negative individuals, whether short-term use of Bikeren Prenol tablets will produce side effects and blocking effects has become a hot topic in medical research.

Studies have shown that Bicronol tablets are safe and effective when used as PEP for 28 days in healthy people In a clinical study, HIV-negative participants received 28 days of treatment with Bicronol tablets after high-risk exposure. All participants did not develop HIV infection after completing treatment, and side effects were mild, mainly manifesting as mild headache, mild diarrhea, or fatigue. This shows that Bikeren Pronol tablets can effectively block HIV virus infection in healthy people and are well tolerated.

It is worth noting that although the overall safety of Bikeren Pronol Tablets is good, individual differences still need to be paid attention to. Especially for people who may have potential renal function problems, renal function assessment should be carried out before starting treatment, and indicators such as serum creatinine and glomerular filtration rate (eGFR) should be monitored regularly during use to ensure the safety of drug use. During use, if obvious discomfort or abnormal kidney function indicators occur, you should consult a doctor in time.

In addition, in order to ensure the efficacy of the drug, it should be taken strictly according to the once-daily dose and avoid missing doses or adjusting the dose by yourself. When used as a 28-day PEP in healthy people, Bikern Prenol Tablets can form a stable blood concentration in a short period of time, thereby effectively blocking HIV infection. Therefore, this drug is not only safe and reliable in PEP applications, but also provides a feasible prevention method for high-risk exposed persons.

Reference materials:https://www.biktarvy.com/